Including Fibroblast Growth Factor-21 in Combined Biomarker Panels Improves Predictions of Liver Steatosis Severity in Children

Background: Previous studies reported conflicting results regarding the association between fibroblast growth factor-21 (FGF-21) and non-alcoholic fatty liver disease (NAFLD). This study aimed to evaluate the feasibility of combining FGF-21, obesity indices, and biochemical tests for predicting high...

Descripción completa

Detalles Bibliográficos
Autores principales: Hua, Man-Chin, Huang, Jing-Long, Hu, Ching-Chih, Yao, Tsung-Chieh, Lai, Ming-Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6842980/
https://www.ncbi.nlm.nih.gov/pubmed/31750276
http://dx.doi.org/10.3389/fped.2019.00420

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6842980/
https://www.ncbi.nlm.nih.gov/pubmed/31750276
http://dx.doi.org/10.3389/fped.2019.00420

Ejemplares similares